Abstract
Altered peptide ligands (APL) with increased MHC-binding properties are highly effective at inducing T cell tolerance after systemic administration in soluble form, preventing experimental autoimmune encephalomyelitis (EAE) induced with the myelin basic protein (MBP) Ac1-9 peptide. We have previously described a diverse Ac1-9-reactive T cell repertoire with differing TCR affinities. A remaining question is what proportion of this repertoire is silenced by peptide therapy? Here, we show that the sensitivity of a T cell to peptide-induced tolerance is related to its avidity for native Ac1-9. These data provide new evidence that self-reactive T cells bearing low-affinity TCRs are able to escape therapeutic induction of tolerance.
Original language | English |
---|---|
Pages (from-to) | 96-106 |
Number of pages | 11 |
Journal | Journal of Neuroimmunology |
Volume | 156 |
Issue number | 1-2 |
DOIs | |
Publication status | Published - Nov 2004 |
Keywords / Materials (for Non-textual outputs)
- Animals
- Autoantigens/administration & dosage
- Cell Line
- Dose-Response Relationship, Immunologic
- Encephalomyelitis, Autoimmune, Experimental/immunology
- Immune Tolerance
- Immunity, Innate
- Immunization
- Lymphocyte Activation/immunology
- Mice
- Mice, Transgenic
- Myelin Basic Protein/administration & dosage
- Peptide Fragments/administration & dosage
- T-Lymphocytes/immunology